Expression of micrornas in patients with pancreatic cancer and its prognostic significance

Pancreas

Volumn 42, Issue 1, 2013, Pages 67-71

  Papaconstantinou, Ioannis G ^a   Manta, Asimina ^a   Gazouli, Maria ^b   Lyberopoulou, Anna ^b   Lykoudis, Panagis M ^a,b   Polymeneas, Giorgos ^a   Voros, Dionysios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

microRNA; miR 21; miRNA expression profile; pancreatic adenocarcinoma

Indexed keywords

MICRORNA 122; MICRORNA 145; MICRORNA 146A; MICRORNA 155; MICRORNA 21; MICRORNA 210; MICRORNA 222; MICRORNA 31;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; UPREGULATION;

AGED; CARCINOMA, PANCREATIC DUCTAL; CASE-CONTROL STUDIES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL;

EID: 84872093873     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182592ba7     Document Type: Article

References (26)

1. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11
2. Saif MW. Pancreatic cancer highlights from the 42nd annual meeting of the American Society of Clinical Oncology, 2006. JOP. 2006; 7(4):337-348.
3. Hayat MJ, Howlader N, Reichman ME, et al. Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist. 2007;12(1):20-37.
4. Sergeant G, Vankelecom H, Gremeaux L, et al. Role of cancer stem cells in pancreatic ductal adenocarcinoma. Nat Rev Clin Oncol. 2009;6(10):580-586.
5. Schneider G, Siveke JT, Eckel F, et al. Pancreatic cancer: basic and clinical aspects. Gastroenterology. 2005;128(6):1606-1625.
6. Hezel AF, Kimmelman AC, Stanger BZ, et al. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev. 2006;20(10): 1218-1249.
7. Jaffee EM, Hruban RH, Canto M, et al. Focus on pancreas cancer. Cancer Cell. 2002;2(1):25-28.
8. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6(11):857-866.
9. Esquela-Kerscher A, Slack FJ. OncomirsVmicroRNAs with a role in cancer. Nat Rev Cancer. 2006;6(4):259-269.
10. Sevignani C, Calin GA, Siracusa LD, et al. Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome. 2006;17(3):189-202.
11. Rachagani S, Kumar S, Batra SK. MicroRNA in pancreatic cancer: pathological, diagnostic and therapeutic implications. Cancer Lett. 2010;292(1):8-16.
12. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009;10(10):704-714.
13. Aaltonen LA, Hamilton SR, World Health Organization., International Agency for Research on Cancer. Pathology and Genetics of Tumours of the Digestive System. Lyon, Oxford: IARC Press; Oxford University Press; 2000.
14. Chira P, Vareli K, Sainis I, et al. Alterations of microRNAs in solid cancers and their prognostic value. Cancers. 2010;2(2):1328-1353.
15. Steele CW, Oien KA, McKay CJ, et al. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. Pancreas. 2011;40(8):1165-1171.
16. Hobert O. Common logic of transcription factor and microRNA action. Trends Biochem Sci. 2004;29(9):462-468.
17. Dillhoff M, Liu J, Frankel W, et al. MicroRNA-21 is overexpressed in pancreatic cancer and a potential predictor of survival. J Gastrointest Surg. 2008;12(12):2171-2176.
18. Moriyama T, Ohuchida K, Mizumoto K, et al. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance. Mol Cancer Ther. 2009;8(5):1067-1074.
19. Hwang JH, Voortman J, Giovannetti E, et al. Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer. PLoS One. 2010;5(5):e10630.
20. Gironella M, Seux M, Xie MJ, et al. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc Natl Acad Sci U S A. 2007;104(41):16170- 16175.
21. Habbe N, Koorstra JB, Mendell JT, et al. MicroRNA miR-155 is a biomarker of early pancreatic neoplasia. Cancer Biol Ther. 2009;8(4):340-346.
22. Lee EJ, Gusev Y, Jiang J, et al. Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer. 2007;120(5): 1046-1054.
23. Zhang Y, Li M, Wang H, et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg. 2009;33(4):698-709.
24. Szafranska AE, Davison TS, John J, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene. 2007;26(30): 4442-4452.
25. Kutay H, Bai S, Datta J, et al. Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem. 2006;99(3):671-678.
26. Lynn FC. Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends Endocrinol Metab. 2009;20(9):452-459.